Important note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
International Federation of Red Cross and Red Cresent Societies - 19 October 2003
In welcoming this move, Dr Massimo Barra, a GFATM board member and veteran of the Italian Red Cross HIV/AIDS and harm reduction response, also called for more programmes that follow humanitarian and public health principles.
"The stigma attached to drug use is causing further marginalization of this most vulnerable group and this is directly impeding efforts to prevent the spread of HIV. Forcing drug-users further underground and into situations where transmission of HIV/AIDS is more likely and denying them access to life-saving treatment and prevention services, is creating a public health disaster," he said.
"This happens even though the evidence from scientific and medical research on best practices and cost benefit analyses is overwhelmingly in favour of harm reduction programming".
The International Federation sees programmes tackling the transmission of HIV/AIDS through shared needle use and the stigma and discrimination associated with it, as essential to the battle against the pandemic. Red Cross societies in Europe, including Russia, have begun such initiatives, including needle exchange and drug treatment.
The approval of the a US$ 1.38 million grant for Care Thailand and US$ 88.7 million for a non-governmental organization (NGO) consortium in Russia came at a meeting of the GFATM board in the northern Thai city of Chiang Mai. It is the first time that the Global Fund has backed harm reduction efforts in South East Asia, parts of which are witnessing an HIV/AIDS epidemic fuelled by injecting drug use.
Injecting drug user groups and NGO's have participated in efforts to develop country specific programmes for Global Fund financing around the world, but have found it difficult to convince some Ministries of the need for programmes to tackle HIV transmission through needle sharing. This despite injecting drug use being the main factor in the HIV/AIDS epidemic in areas such as Eastern Europe.
The grants to Thailand and Russia was one piece of positive news emerging from this latest GFATM board meeting. The Fund is still dramatically short of money promised by rich countries to scale up the HIV/AIDS battle as agreed at a special UN General Assembly (UNGASS) two years ago in New York. In this funding round, fewer people will be given access to anti-retroviral treatment through Global Fund money than on previous funding rounds, particularly in Africa. This despite global targets to increase the number of people with access to HIV/AIDS treatment.
"This is just not good enough. The Fund should be growing ? not shrinking," said Bernard Gardiner, manager of the International Federation's global HIV/AIDS programme. "At UNGASS, all countries agreed to specific objectives to stop HIV/AIDS. It is not only time to honour those promises to keep people alive, but imperative to do so."
For further information, or to set up interviews (ISDN line available), please contact:
In Geneva
Jemini Pandya, Press Officer Tel: + 41 79 217 33 74 /+41 22 730 4570
Media Service Duty Phone Tel: + 41 79 416 38 81
In Bangkok
Rosemarie North, Regional Information Delegate Tel: + 661 823 9218
031019
IF031002
Copyright © 2003 - International Federation of Red Cross and Red Crescent Societies. Reproduction of this article (other than one copy for personal reference) must be cleared through the IFRC Contact.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .